HALO · Halozyme Therapeutics, Inc. · Fails to Deliver
$110.40
+0.00 (+0.00%)
At close · Oct 1
Return incl. dividend (before tax)
Market Cap
$12.93B
Shares
113.50M
Volume · Sep 30
3.52M
Avg daily vol (3M)
2.16M
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-08-31 | 395 | $105.35 | $41,613 |
| 2026-08-28 | 7,839 | $106.92 | $838,146 |
| 2026-08-25 | 22,676 | $108.64 | $2,463,521 |
| 2026-08-18 | 3,853 | $103.00 | $396,859 |
| 2026-08-17 | 704 | $98.66 | $69,457 |
| 2026-08-13 | 14 | $101.79 | $1,425 |
| 2026-08-10 | 871 | $103.12 | $89,818 |
| 2026-08-07 | 4,876 | $85.76 | $418,166 |
| 2026-08-06 | 41 | $83.59 | $3,427 |
| 2026-08-05 | 108 | $83.23 | $8,989 |
| 2026-08-03 | 305 | $82.54 | $25,175 |
| 2026-07-31 | 1,515 | $83.30 | $126,200 |
| 2026-07-30 | 4,780 | $83.28 | $398,078 |
| 2026-07-23 | 50 | $77.82 | $3,891 |
| 2026-07-22 | 138 | $78.60 | $10,847 |
| 2026-07-21 | 18,373 | $77.09 | $1,416,375 |
| 2026-07-17 | 261 | $77.54 | $20,238 |
| 2026-07-15 | 17,716 | $75.05 | $1,329,586 |
| 2026-07-09 | 750 | $80.37 | $60,278 |
| 2026-07-06 | 4,643 | $79.45 | $368,886 |
Showing 1–20 of 20 settlements
Key facts
CIK
1159036
CUSIP
40637H109
13F (30d)
21 filings
16 filers
Visit website
Investor relations